DGM
EW icon

Delta Global Management’s Edwards Lifesciences EW Stock Holding History

Delta Global Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,175
Closed -$1.89M – 182
2025
Q4 		$1.89M Buy
+22,175
New +$1.82M 0.14% 123

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Delta Global Management's EW Position: Q1 2026 in Review

Delta Global Management sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 22,175 shares — an estimated $1.89M sold.

Delta Global Management first reported a position in EW in Q4 2025 and held it in 1 quarter. The position peaked at $1.89M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Delta Global Management reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Delta Global Management sold 22,175 Edwards Lifesciences shares in Q1 2026, an estimated $1.89M.
  • Delta Global Management first reported a position in Edwards Lifesciences in Q4 2025 and held it in 1 quarter.
  • Delta Global Management's Edwards Lifesciences position peaked at $1.89M in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Delta Global Management's 13F filing for Q1 2026, filed 15 May 2026.